相关实验视频

Updated: Jul 27, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

PNPLA3-I148M变体通过诱导线粒体功能障碍促进肝纤维化进展

Yusong Gou^1,2, Lifei Wang³, Jinhan Zhao^1,2

¹The Third Unit, The Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

International journal of molecular sciences

|June 10, 2023

概括

这种PNPLA3 I148M变体通过导致肝细胞中自由胆固醇的积累来促进肝纤维化. 这导致线粒体功能障碍,促进肝细胞活化和纤维化进展.

科学领域:

肝病学肝病学是一种肝病学.
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

含有3 (PNPLA3) rs738409多态 (I148M) 的帕塔丁类脂酶域与非酒精性脂肪肝炎和晚期肝纤维化有关.
驱动这种关联的精确分子机制尚未完全理解.

研究的目的:

调查PNPLA3-I148M变异如何影响肝星细胞激活和肝纤维化进展.
阐明PNPLA3-I148M在细胞胆固醇代谢和线粒体功能中的作用.

主要方法:

利用免疫光染色和ELISA来量化LX-2细胞中的脂质积累.
通过实时PCR和西部涂抹,测量纤维化,胆固醇代谢和线粒体相关标记物的表达.
通过电子显微镜分析了线粒体超结构,并使用海马XFe96分析仪评估了线粒体呼吸.

主要成果:

通过减少ABCG1表达,PNPLA3-I148M在LX-2细胞中诱导了细胞内自由胆固醇聚合.
这种胆固醇积累导致线粒体功能障碍,包括减少ATP的产生,降低线粒体膜潜力,增加ROS,结构损伤和改变氧气消耗.
线粒体功能标记物的表达显著下降.

结论:

通过自由胆固醇的积累,PNPLA3-I148M会导致肝星细胞中的线粒体功能障碍.
这种功能障碍促进LX-2细胞的激活,并有助于肝纤维化的发展.

关键词:

这是一种PNPLA3-I148M.免费胆固醇是什么意思肝脏的恒星细胞.肝脏纤维化肝脏纤维化线粒体中的线粒体.

更多相关视频

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

相关概念视频

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...